Yaqrit
London
About Yaqrit
Yaqrit, a clinical-stage company, is dedicated to pioneering innovative treatments for patients suffering from advanced liver disease, particularly those facing high risks of hospitalization and mortality. Its robust pipeline includes three cutting-edge therapeutics in Phase 2-3 development and two state-of-the-art medical devices. Yaqrit is currently preparing for Phase 3 clinical trials for its ammonia scavenger treatment, crucial for patients with hepatic conditions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $20.7M
- Funding stage: Private Equity
- Last round: Grant (Mar 2025)
- Website: yaqrit.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Life Science, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/yaqrit-149614 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.